Evidence map›Paper›PMID 39063895›Full record

ReviewMaterials (Basel, Switzerland)2024

Biochar from Co-Pyrolyzed Municipal Sewage Sludge (MSS): Part 1: Evaluating Types of Co-Substrates and Co-Pyrolysis Conditions.

Michael Biney, Mariusz Z Gusiatin

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michael BineyDepartment of Environmental Biotechnology, Faculty of Geoengineering, University of Warmia and Mazury in Olsztyn, Sloneczna Str. 45G, 10-709 Olsztyn, Poland.ORCID 0000-0002-3337-0628
Mariusz Z GusiatinDepartment of Environmental Biotechnology, Faculty of Geoengineering, University of Warmia and Mazury in Olsztyn, Sloneczna Str. 45G, 10-709 Olsztyn, Poland.ORCID 0000-0002-5402-6893

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the increasing production of municipal sewage sludge (MSS) worldwide, the development of efficient and sustainable strategies for its management is crucial. Pyrolysis of MSS offers several benefits, including volume reduction, pathogen elimination, and energy recovery through the production of biochar, syngas, and bio-oil. However, the process can be limited by the composition of the MSS, which can affect the quality of the biochar. Co-pyrolysis has emerged as a promising solution for the sustainable management of MSS, reducing the toxicity of biochar and improving its physical and chemical properties to expand its potential applications. This review discusses the status of MSS as a feedstock for biochar production. It describes the types and properties of various co-substrates grouped according to European biochar certification requirements, including those from forestry and wood processing, agriculture, food processing residues, recycling, anaerobic digestion, and other sources. In addition, the review addresses the optimization of co-pyrolysis conditions, including the type of furnace, mixing ratio of MSS and co-substrate, co-pyrolysis temperature, residence time, heating rate, type of inert gas, and flow rate. This overview shows the potential of different biomass types for the upgrading of MSS biochar and provides a basis for research into new co-substrates. This approach not only mitigates the environmental impact of MSS but also contributes to the wider goal of achieving a circular economy in MSS management.

Indexed as

biocharbiomassco-pyrolysismunicipal sewage sludgewaste

Identifiers

PMID39063895
PMCPMC11278580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.